enEvolv: MAGE - Multiplex Automated Genome Engineering Generates Billions of Variants: The Digest's 2020 Multi-Slide Guide to enEvolv's Genome Engineering

enEvolv produces biobased chemicals for the energy, specialty chemicals, nutrition and therapeutics industries, develops novel strains and improves existing ones focusing on their ultra-rapid genome engineering platform. Marco Farsheed, enEvolv's Co-Founder and CEO shared this illuminating presentation on why strain engineering is challenging, how enEvolv's variation technology improves the economics and effectiveness of strain engineering which [...]